Biogen Inc. stock underperforms Friday when compared to competitors
Shares of Biogen Inc. BIIB slipped 1.40% to $138.37 Friday, on what proved to be an all-around rough trading session for the ...
Biogen Must Face Investors' Claim on Alzheimer's Drug Trial Data
Biogen Inc. investors can advance their claim that the company misrepresented clinical trial data for its Alzheimer’s drug, a federal judge ruled.
The Maine Monitor2d
What’s behind that organic label?
The label organic — which in Maine can be denoted by either the USDA or MOFGA — is consistent across the country, and means ...
Biogen Inc. stock underperforms Thursday when compared to competitors
Biogen Inc. closed 41.04% below its 52-week high of $238.00, which the company achieved on July 12th.
Biogen: Balancing Risks And Opportunities
Biogen enhances its portfolio and margins amidst market challenges and competition. Click here to find out why BIIB stock is ...
Transgene Achieves Key Milestones in 2024, Including Clinical Proof of Principle for Individualized Cancer Vaccine ̶ Strong Outlook for 2025
Full-year results and business updateClinical proof of principle obtained in Phase I adjuvant head and neck cancer trial with individualized ...
Craft Brewing Business3d
Details on Stoic Cider’s rebranding and new visual identity
The Stoic Cider rebranding includes a refreshed visual identity and innovative can packaging to elevates Stoic’s presence in ...